Multiple myeloma trials in United States
297 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleIberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma
- Where
- Miami
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Benjamin T Diamond, MD
See details and how to joinNCT05896228 - Phase 1Taking peopleLymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function
- Where
- St Louis
- Age
- 18 years and over
- People
- 16
- Run by
- Washington University School of Medicine
See details and how to joinNCT06623630 - Phase 2Taking peopleA Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 17
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06066346 - Phase 2Taking peopleSelinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma
- Where
- Coral Gables, Deerfield Beach, Miami
- Age
- 18 years and over
- People
- 33
- Run by
- University of Miami
See details and how to joinNCT05530421 - Phase 2Taking peopleTeclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)
- Where
- Miami
- Age
- 18 years and over
- People
- 50
- Run by
- Carl Ola Landgren, MD, PhD
See details and how to joinNCT06100237 - Phase 2Taking peopleElranatamab in Relapsed/Refractory Multiple Myeloma
- Where
- La Jolla
- Age
- 18 years and over
- People
- 33
- Run by
- University of California, San Diego
See details and how to joinNCT06711705 - No phaseTaking peopleA Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
- Where
- Duarte, Goodyear, Huntington Beach, Irvine, Long Beach, Newnan, Newport Beach, South Pasadena, Upland, West Covina, Zion
- Age
- 18 years and over
- People
- 700
- Run by
- City of Hope Medical Center
See details and how to joinNCT07225738 - No phaseTaking peopleSmoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
- Where
- Salt Lake City
- Age
- 18 years and over
- People
- 100
- Run by
- University of Utah
See details and how to joinNCT06212323 - Early phase 1Taking peopleIn-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
- Where
- New York
- Age
- 18 years and over
- People
- 30
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05093335 - No phaseTaking peopleMultimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy
- Where
- Salt Lake City
- Age
- 21 years and over
- People
- 40
- Run by
- University of Utah
See details and how to joinNCT07390071 - Phase 2Taking peopleBortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency
- Where
- Milwaukee
- Age
- 18 years and over
- People
- 41
- Run by
- Medical College of Wisconsin
See details and how to joinNCT04240054 - No phaseTaking peopleAscertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
- Where
- Basking Ridge, Commack, Harrison, Middletown, New York, Rockville Centre
- People
- 500
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT00582621 - No phaseTaking peoplePrehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
- Where
- Boston
- Age
- 18 years and over
- People
- 30
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT05706766 - No phaseTaking peopleTransgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
- Where
- Dallas, Madison, Portland, Salt Lake City
- People
- 50 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06357754 - Phase 2Taking peopleIsatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma
- Where
- Boston
- Age
- 18 years and over
- People
- 50
- Run by
- Massachusetts General Hospital
See details and how to joinNCT05922501 - Phase 2Taking peopleLinvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse
- Where
- Miami
- People
- 32
- Run by
- Dickran Kazandjian, MD
See details and how to joinNCT06910124 - Phase 1Taking peopleCilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma
- Where
- Milwaukee
- Age
- 18 years and over
- People
- 31
- Run by
- Medical College of Wisconsin
See details and how to joinNCT07093554 - Phase 2Taking peopleMinimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
- Where
- Birmingham
- Age
- 18 years and over
- People
- 40
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT04991103 - No phaseTaking peoplePrehabilitation Feasibility Among Older Adults Undergoing Transplantation
- Where
- Birmingham
- Age
- 60 years and over
- People
- 30
- Run by
- Noha Mohamed Sharafeldin
See details and how to joinNCT05642884 - Phase 1Taking peopleFree From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD
- Where
- Chicago
- Age
- 18 years and over
- People
- 50
- Run by
- University of Illinois Chicago
See details and how to joinNCT05192122 - No phaseTaking peopleCancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
- Where
- Birmingham
- Age
- 50 years and over
- People
- 5,000
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT05556928 - Phase 2Taking peopleElranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma
- Where
- Tampa
- Age
- 18 years and over
- People
- 39
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06947083 - No phaseTaking peopleCollection of Samples and Clinical Data From Patients With Amyloid Diseases
- Where
- Boston
- Age
- 18 years and over
- People
- 10,000
- Run by
- Boston Medical Center
See details and how to joinNCT00898235 - Phase 2Taking peopleMozobil for Autologous Hematopoietic Stem Cell Transplantation
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 100
- Run by
- Thomas Jefferson University
See details and how to joinNCT07188090 - No phaseTaking peopleRegistry for Adults With Plasma Cell Disorders (PCD's)
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 2,000
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT03717844